首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Pharmacogenomics journal

缩写:PHARMACOGENOMICS J

ISSN:1470-269X

e-ISSN:1473-1150

IF/分区:2.9/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引1101
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Mohammed Khattab,Mohamed Baguneid,George P Patrinos et al. Mohammed Khattab et al.
Genetic variation in CYP2C19 is linked to variable efficacy in antiplatelet therapies like clopidogrel. Patients with CYP2C19*2 and *3 loss of function alleles show reduced enzyme function, leading to lower active drug levels and higher ris...
Astrid Johannesson Hjelholt,Tahereh Gholipourshahraki,Zhonghao Bai et al. Astrid Johannesson Hjelholt et al.
Type 2 diabetes (T2D) is a complex, polygenic disease with substantial health impact. Despite extensive genome-wide association studies (GWAS) identifying risk loci, therapeutic translation remains limited. We applied a Bayesian Linear Regr...
Wei Zhuang,Yi Zeng,Xinping Lin et al. Wei Zhuang et al.
Imatinib is associated with significant toxicities, including myelosuppression, oedema, and hypersensitivity, with considerable interpatient variability. Pharmacokinetic and pharmacogenomic factors contribute, but comprehensive biomarkers a...
Vinh Hoa Pham,Sang-Heon Kim,Young-Koo Jee et al. Vinh Hoa Pham et al.
It has been proposed that mitochondrial DNA variations can affect mitochondrial function, increasing the risk of drug-induced liver injury. This study aims to explore the association between mitochondrial DNA (mtDNA) variants and anti-tuber...
Anna Shteto,Jawad Boulahfa,Adrien Etcheto et al. Anna Shteto et al.
Predictive safety risk biomarkers for drug-induced liver injury (DILI) are critically needed to enhance patient risk stratification and minimize adverse outcomes. This study aims to identify genomic markers associated with increased mortali...
Ruby Soueid,Toni J F Michael,Pete Yeap et al. Ruby Soueid et al.
Pharmacogenomic services are commonly pharmacist-led, yet pharmacists report poor knowledge and confidence in application. This study evaluated an experiential teaching approach to enhance students' confidence and knowledge in pharmacogenom...
Yazun Jarrar,Nancy Hakooz,Dina Abu Hashem et al. Yazun Jarrar et al.
Introduction: Pharmacogenomics (PGx) testing aims to identify the most appropriate drug and dose for individual patients based on their genetic profiles. In Jordan, patients with genetic disorders often use multiple medic...
William P Duggan,Mohammedreza Azimi,Lyndsey Flanagan et al. William P Duggan et al.
5-15% of all colorectal cancers (CRCs) are mucinous. Mucinous CRCs are associated with an inhibited response to standard adjuvant and neoadjuvant therapies. Serine-Arginine Protein Kinase 1 (SRPK1) is an enzyme, which modulates the activity...
Ryley Uber,Vanessa A Hayduk,Alison Flango et al. Ryley Uber et al.
Pharmacogenomics (PGx) test results are returned variably across healthcare settings, which can lead to challenges particularly when results require immediate intervention to avoid adverse consequences. While several return of result models...